RALLIS
Rallis India Limited
Crop protection and seeds company with agrochemicals and cotton/maize seeds
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
rallis.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Rallis India sells crop protection products (insecticides, herbicides and fungicides), seeds and soil and plant health products to Indian farmers through dealers and distributors, and also exports agrochemicals and supplies other companies under contract.
Company snapshot
6thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
What we see
- ✓Debt-to-equity of 0.05x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 832 Cr | 598 Cr | 436 Cr | 783 Cr | 928 Cr | 522 Cr | 430 Cr | 957 Cr | 861 Cr | 623 Cr | 456 Cr | 1,022 Cr |
| Operating expenses (approx.) | 699 Cr | 536 Cr | 430 Cr | 687 Cr | 762 Cr | 478 Cr | 450 Cr | 807 Cr | 707 Cr | 565 Cr | 457 Cr | 837 Cr |
| EBITDA | 133 Cr | 62 Cr | 6 Cr | 96 Cr | 166 Cr | 44 Cr | -20 Cr | 150 Cr | 154 Cr | 58 Cr | -1 Cr | 185 Cr |
| OPM % | 16.0% | 10.4% | 1.4% | 12.3% | 17.9% | 8.4% | -4.7% | 15.7% | 17.9% | 9.3% | -0.2% | 18.1% |
| Other income | 5 Cr | 2 Cr | 6 Cr | 5 Cr | 10 Cr | 6 Cr | 11 Cr | 12 Cr | 10 Cr | 9 Cr | 11 Cr | 13 Cr |
| Interest | 3 Cr | 4 Cr | 8 Cr | 5 Cr | 3 Cr | 2 Cr | 2 Cr | 4 Cr | 3 Cr | 2 Cr | 1 Cr | 2 Cr |
| Depreciation | 26 Cr | 30 Cr | 33 Cr | 31 Cr | 30 Cr | 29 Cr | 30 Cr | 29 Cr | 30 Cr | 29 Cr | 29 Cr | 30 Cr |
| Profit before tax | 110 Cr | 30 Cr | -29 Cr | 65 Cr | 143 Cr | 19 Cr | -40 Cr | 129 Cr | 137 Cr | 1 Cr | -17 Cr | 168 Cr |
| Tax % | 25.5% | 20.0% | 27.6% | 26.2% | 31.5% | 42.1% | 20.0% | 26.4% | 25.5% | -100.0% | 11.8% | 25.6% |
| Net profit | 82 Cr | 24 Cr | -21 Cr | 48 Cr | 98 Cr | 11 Cr | -32 Cr | 95 Cr | 102 Cr | 2 Cr | -15 Cr | 125 Cr |
| EPS (₹) | ₹4.23 | ₹1.25 | ₹-1.07 | ₹2.46 | ₹5.04 | ₹0.56 | ₹-1.67 | ₹4.89 | ₹5.23 | ₹0.10 | ₹-0.79 | ₹6.43 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,490 Cr | 1,516 Cr | 1,672 Cr | 2,252 Cr | 2,429 Cr | 2,604 Cr | 2,967 Cr | 2,648 Cr | 2,663 Cr | 2,897 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,255 Cr | 1,290 Cr | 1,465 Cr | 1,990 Cr | 2,106 Cr | 2,330 Cr | 2,749 Cr | 2,337 Cr | 2,377 Cr | 2,536 Cr | Sign in free for the trailing twelve months |
| EBITDA | 235 Cr | 226 Cr | 206 Cr | 261 Cr | 323 Cr | 274 Cr | 218 Cr | 311 Cr | 286 Cr | 361 Cr | Sign in free for the trailing twelve months |
| OPM % | 15.8% | 14.9% | 12.3% | 11.6% | 13.3% | 10.5% | 7.4% | 11.7% | 10.7% | 12.5% | Sign in free for the trailing twelve months |
| Other income | 11 Cr | 9 Cr | 26 Cr | 34 Cr | 40 Cr | 27 Cr | 13 Cr | 16 Cr | 32 Cr | 42 Cr | Sign in free for the trailing twelve months |
| Interest | 3 Cr | 3 Cr | 5 Cr | 6 Cr | 5 Cr | 5 Cr | 12 Cr | 18 Cr | 12 Cr | 10 Cr | Sign in free for the trailing twelve months |
| Depreciation | 42 Cr | 41 Cr | 39 Cr | 62 Cr | 64 Cr | 74 Cr | 91 Cr | 114 Cr | 120 Cr | 117 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 359 Cr | 191 Cr | 188 Cr | 239 Cr | 304 Cr | 222 Cr | 128 Cr | 196 Cr | 187 Cr | 250 Cr | Sign in free for the trailing twelve months |
| Tax % | 26.0% | 26.0% | 31.3% | 22.5% | 24.7% | 26.2% | 28.2% | 24.5% | 33.2% | 26.4% | Sign in free for the trailing twelve months |
| Net profit | 266 Cr | 141 Cr | 129 Cr | 185 Cr | 229 Cr | 164 Cr | 92 Cr | 148 Cr | 125 Cr | 184 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹13.68 | ₹7.28 | ₹6.63 | ₹9.54 | ₹11.76 | ₹8.45 | ₹4.73 | ₹7.61 | ₹6.43 | ₹9.46 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 21.3% | 35.6% | 63.5% | 33.1% | 39.2% | 26.6% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr | 19 Cr |
| Reserves | 1,106 Cr | 1,159 Cr | 1,229 Cr | 1,391 Cr | 1,572 Cr | 1,677 Cr | 1,711 Cr | 1,810 Cr | 1,885 Cr | 2,024 Cr |
| Borrowings | 21 Cr | 18 Cr | 68 Cr | 76 Cr | 59 Cr | 93 Cr | 137 Cr | 133 Cr | 63 Cr | 7 Cr |
| Other liabilities | 404 Cr | 537 Cr | 539 Cr | 961 Cr | 937 Cr | 1,069 Cr | 931 Cr | 1,041 Cr | 1,007 Cr | 1,295 Cr |
| Total liabilities | 1,551 Cr | 1,733 Cr | 1,855 Cr | 2,447 Cr | 2,587 Cr | 2,858 Cr | 2,798 Cr | 3,003 Cr | 2,974 Cr | 3,345 Cr |
| Fixed assets (net) | 338 Cr | 343 Cr | 349 Cr | 387 Cr | 424 Cr | 564 Cr | 550 Cr | 788 Cr | 680 Cr | 580 Cr |
| CWIP | 12 Cr | 12 Cr | 13 Cr | 29 Cr | 106 Cr | 56 Cr | 179 Cr | 19 Cr | 25 Cr | 11 Cr |
| Investments | 534 Cr | 390 Cr | 374 Cr | 303 Cr | 284 Cr | 212 Cr | 223 Cr | 252 Cr | 413 Cr | 507 Cr |
| Inventories | 244 Cr | 375 Cr | 430 Cr | 699 Cr | 763 Cr | 938 Cr | 793 Cr | 808 Cr | 751 Cr | 959 Cr |
| Trade receivables | 226 Cr | 365 Cr | 417 Cr | 450 Cr | 406 Cr | 446 Cr | 499 Cr | 579 Cr | 541 Cr | 616 Cr |
| Cash & bank | 4 Cr | 3 Cr | 35 Cr | 46 Cr | 9 Cr | 11 Cr | 44 Cr | 27 Cr | 28 Cr | 39 Cr |
| Other assets | 192 Cr | 246 Cr | 237 Cr | 534 Cr | 595 Cr | 632 Cr | 510 Cr | 530 Cr | 536 Cr | 633 Cr |
| Total assets | 1,551 Cr | 1,733 Cr | 1,855 Cr | 2,447 Cr | 2,587 Cr | 2,858 Cr | 2,798 Cr | 3,003 Cr | 2,974 Cr | 3,345 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 353 Cr | -5 Cr | 55 Cr | 338 Cr | 216 Cr | 166 Cr | 217 Cr | 269 Cr | 295 Cr | 172 Cr |
| Cash from investing | -275 Cr | 95 Cr | -9 Cr | -246 Cr | -162 Cr | -103 Cr | -142 Cr | -102 Cr | -214 Cr | -95 Cr |
| Cash from financing | -74 Cr | -92 Cr | -50 Cr | -74 Cr | -67 Cr | -61 Cr | -41 Cr | -184 Cr | -80 Cr | -66 Cr |
| Net cash flow | 3 Cr | -1 Cr | -4 Cr | 18 Cr | -13 Cr | 1 Cr | 34 Cr | -17 Cr | 1 Cr | 11 Cr |
| Free cash flow (OCF − Capex) | 297 Cr | -54 Cr | 21 Cr | 259 Cr | 48 Cr | -19 Cr | 29 Cr | 187 Cr | 221 Cr | 127 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|
| ROCE % | 33.7% | 19.1% | 16.6% | 16.4% | 18.7% | 12.8% |
| ROE % | 26.8% | 14.1% | 12.1% | 13.1% | 14.4% | 9.7% |
| Debtor days | 54 | 80 | 82 | 73 | 61 | 62 |
| Inventory days | 181 | 231 | 205 | 199 | 197 | 219 |
| Days payable | 151 | 214 | 163 | 181 | 154 | 175 |
| Cash conversion cycle | 84 | 97 | 125 | 91 | 104 | 106 |
| OCF / EBITDA % | 154.6% | 15.6% | 33.2% | 129.9% | 67.1% | 60.5% |
| OCF / EBITDA % (3 years) | — | — | 68.8% | 59.9% | 77.0% | 84.0% |
| Debt / equity | 0.03 | 0.02 | 0.05 | 0.05 | 0.04 | 0.05 |
| Current ratio | 1.83 | 1.71 | 1.74 | 1.69 | 1.81 | 1.66 |
| Net debt / EBITDA | 0.12 | -0.03 | 0.11 | 0.12 | 0.15 | 0.25 |